BioAtla (BCAB)
(Delayed Data from NSDQ)
$1.89 USD
+0.09 (5.00%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.89 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BCAB 1.89 +0.09(5.00%)
Will BCAB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BCAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCAB
Does BioAtla, Inc. (BCAB) Have the Potential to Rally 114% as Wall Street Analysts Expect?
Can BioAtla, Inc. (BCAB) Climb 260% to Reach the Level Wall Street Analysts Expect?
BCAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
BioAtla, Inc. (BCAB) Reports Q3 Loss, Lags Revenue Estimates
BioAtla, Inc. (BCAB) Reports Q2 Loss, Lags Revenue Estimates
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates
Other News for BCAB
BioAtla management to meet virtually with BTIG
'Big Short' Fame Michael Burry Bets Big On China, Reveals Alibaba As Top Holding — JD.com And Baidu Also Feature On Scion's Portfolio
BioAtla management to meet virtually with BTIG
BioAtla management to meet virtually with BTIG
Michael Burry's Scion Asset sheds Safe Bulkers, adds Hudson Pacific, others in Q2